Article Text

Download PDFPDF
Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C.
  1. R Pérez,
  2. R Pravia,
  3. A Linares,
  4. M Rodríguez,
  5. J L Lombraña,
  6. A Suárez,
  7. S Riestra,
  8. C A Navascués,
  9. L Rodrigo
  1. Gastroenterology Unit, Hospital Central de Asturias, School of Medicine, Oviedo, Spain.


    In an analysis of the clinical and laboratory variables that can influence the response to interferon alfa-2b treatment, 48 patients with chronic hepatitis C virus infection received interferon 5 million units (MU) subcutaneously three times weekly for eight weeks followed by 3 MU three times weekly for seven months. Response related factors on univariate analysis were found to be age > 40 years, non-parenteral source of infection, pretreatment positive antinuclear antibodies (ANA), cirrhosis, and high serum iron, ferritin, gamma glutamyl transferase, and IgM. An independent predictive value (multivariate analysis) was also found for cirrhosis, ANA, serum iron, and ferritin. A baseline aspartate aminotransferase/alanine aminotransferase ratio of 0.5 and a striking increase during interferon treatment were associated with a complete response.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.